

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1251 daily bars · split adjusted
Current price $0.00
Latest analyst grade actions
Daily · Wilder smoothing
Classic floor pivots from 2026-10-20
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 51.85 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 50.00 | Oscillator | Neutral |
| Williams %R (14) | -50.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.00 (Hist -0.00) | Oscillator | Sell |
| Average Directional Index (14) | NaN (+DI 51.9 / -DI 48.1) | Trend | Buy |
| EMA 20 | 0.00 | MA | Buy |
| SMA 20 | 0.00 | MA | Buy |
| EMA 50 | 0.00 | MA | Buy |
| SMA 50 | 0.00 | MA | Buy |
| SMA 200 | 0.00 | MA | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Koninklijke KPN is exiting a heavy capex cycle, positioning for a 20% capex reduction by 2027 and significant free cash flow growth. KKPNY targets a 3% CAGR in revenue and EBITDAaL and a 7% CAGR in free cash flow, supporting robust dividend growth. 2027 guidance implies €1.1B free cash flow and a 25 eurocent dividend per share, yielding over 6% at current prices.
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reductio
On Holding (ONON) has seen a significant rise in its stock price following its Investor Day, where it unveiled ambitious financial targets for 2029 alongside it
TASE Presents 2027-2031 Strategic Plan to Accelerate Revenue Growth, Expand International Activity and Create Long-Term Shareholder Value Targets 15%-18% Revenu
The plan positions TASE for accelerated growth through broader global access, increased use of foreign currency in trading and stronger, technology-enabled market infrastructure TEL AVIV, Israel, Sept. 16, 2026 /PRNewswire/ -- The Tel Aviv Stock Exchange (TASE: TASE) today announced its new strategic plan for fiscal years 2027-2031, following its approval by the Board of Directors.
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News
HONG KONG, Aug 25, 2026 - (ACN Newswire) - Mech-Mind Robot (stock code: 09615.HK) today officially commenced its initial public offering, with a proposed price
L3Harris Technologies targets 8% organic revenue CAGR and 15%+ cash flow CAGR through 2028, underpinned by robust defense demand. The pending Missile Solutions IPO, now delayed to mid-2027, is expected to unlock further shareholder value as the segment nears its growth inflection. LHX is trading below its five-year average valuation despite sector tailwinds and elevated growth prospects, presenting a compelling entry point.
Reported EPS vs. consensus estimate
TTM vs. 5-year historical average (annual ratios)
| Metric | CAGR | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.0x | -725.0x · sector 38.2x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | -0.0x | -22719.3x | Discount |
| Price / Sales | 0.0x | 174.3x | Discount |
| EV / EBITDA | -0.6x | -813.6x | Discount |
| Return on equity | 3217.4% | — | Top tier |
| Gross margin | 4.5% | 4.5% | In line |
| Debt / Equity | -16.45 | -16.45 | Conservative |
| Piotroski / Altman Z | —/9 | Z — | n/a |
Discounted cash flow model